Female Health Co  

(Public, NASDAQ:FHCO)   Watch this stock  
Find more results for FHCO
1.50
-0.07 (-4.46%)
Feb 9 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.47 - 1.58
52 week 1.16 - 3.97
Open 1.58
Vol / Avg. 222,982.00/213,965.00
Mkt cap 41.31M
P/E 8.62
Div/yield     -
EPS 0.17
Shares 29.03M
Beta 1.19
Inst. own 21%
Apr 28, 2016
Q2 2016 Female Health Co Earnings Release (Estimated) Add to calendar
Feb 2, 2016
Q1 2016 Female Health Co Earnings Call
Feb 2, 2016
Q1 2016 Female Health Co Earnings Release
Dec 1, 2015
Q3 2015 Female Health Co Earnings Call
Dec 1, 2015
Q3 2015 Female Health Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 18.11% 13.33%
Operating margin 29.07% 20.30%
EBITD margin - 21.81%
Return on average assets 15.57% 12.57%
Return on average equity 17.62% 14.20%
Employees 180 -
CDP Score - -

Address

STE 2225, 515 NORTH STATE STREET
CHICAGO, IL 60610
United States - Map
+1-312-5959123 (Phone)
+1-312-5959122 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Female Health Company, is a Female Condom company. The Company is engaged in manufacturing, marketing and selling FC2 Female Condom (FC2). FC2 is used for both disease prevention and family planning, the public health sector is the Company’s market. The Company operates in one industry segment which includes the development, manufacture and marketing of consumer health care products. The FC2 product offered by the Company facilitates dual protection for women against both unintended pregnancy and STIs, including HIV and AIDS, its market encompasses both family planning and disease prevention. FC2’s primary usages are for disease prevention and family planning, the public health sector is the Company’s main market. The Company markets products that prevent the transmission of HIV and AIDS through sexual intercourse: the male condom and FC2.

Officers and directors

Overton B. Parrish Jr. Chairman of the Board, Chief Executive Officer
Age: 82
Bio & Compensation  - Reuters
Michele Greco Chief Financial Officer, Executive Vice President, IR Contact Officer
Age: 57
Bio & Compensation  - Reuters
Susan Ostrowski Executive Vice President - Sales and Marketing
Age: 59
Bio & Compensation  - Reuters
Martin Clifford Tayler Executive Vice President - Global Operations
Age: 47
Bio & Compensation  - Reuters
William R. Gargiulo Jr. Secretary, Independent Director
Age: 86
Bio & Compensation  - Reuters
David R. Bethune Independent Director
Age: 75
Bio & Compensation  - Reuters
Donna Felch Independent Director
Age: 68
Bio & Compensation  - Reuters
Mary Margaret Frank Ph.D. Independent Director
Age: 47
Bio & Compensation  - Reuters
Andrew S. Love Jr. Independent Director
Age: 72
Bio & Compensation  - Reuters
Sharon Meckes Independent Director
Age: 50
Bio & Compensation  - Reuters